TLR4 and breast cancer: PBMCs from breast cancer patients also exhibited increased TNF-α expression and protein production in response to PSP, an effect not abrogated by blockade of toll-like receptor 4 (TLR4), suggesting that PSP is independent of TLR4 activation (8).